Market revenue in 2023 | USD 1,249.4 million |
Market revenue in 2030 | USD 1,849.4 million |
Growth rate | 5.8% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Biotech |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 73.62% in 2023. Horizon Databook has segmented the Germany high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has one of the strongest healthcare systems in terms of advanced infrastructure. In 2018, around 11.7% of the GDP, i.e., EUR 390.6 billion was spent on healthcare. The expenditure was estimated to increase by 4% in 2019 and reach EUR 407.4 billion. According to the UN population data, one in every 20 Germans is aged above 80 and the number is expected to increase to six by 2050.
Increasing geriatric population is responsible for the rising incidence of age-related disorders, such as neurological disorders, diabetes, cancer, and cardiovascular disorders. Growing prevalence of chronic diseases and high healthcare expenditure are expected to propel the market growth.
High prevalence of cancer in the region is another major factor fueling the market growth in Germany. According to The Global Cancer Observatory, the number of new cancer cases in the country was 608,742 in 2018. Breast, lung, prostate, colorectal, and bladder cancers are some of the most prevalent types of cancer in the nation.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Germany high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account